Lenimen Biotech Private Limited, a active private limited company, was established on 18 March 2014 in Aluva, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232KL2014PTC036433. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Abdul Rahman Parappath Shibili (Director), Pazhangat Kochumarakat Nazar (Managing Director), Shahid Rahman Manthedath (Director). Past directors included Remya Mohan, Pazhangat Kochumarakat Nazar, Kalayil Varghese Siji. Its latest AGM occurred on 30 August 2024, with the balance sheet filed on 31 March 2023. It is based at 2/76 B Ckk Building,Thottumugam, Aluva, Kerala, 683105.
U24232KL2014PTC036433
036433
18 March 2014
₹0.10 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Lenimen Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abdul Rahman Parappath Shibili | Director | 18 Mar 2014 | Current |
| Pazhangat Kochumarakat Nazar | Managing Director | 18 Mar 2014 | Current |
| Shahid Rahman Manthedath | Director | 18 Mar 2014 | Current |
| Midhul Sasidharan Nair | Director | 18 Mar 2014 | Current |
| Saji Subrahmanyan | Director | 08 Apr 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Apr 2019 | Past |
| Pramod Abcsdd | Director | 02 Jan 2024 | Past |
| Pramod Abcsdd | Director | 26 Feb 2016 | Past |
| Pramod Abcsdd | Director | 20 Oct 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lenimen Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.89% increase. The company also saw a substantial improvement in profitability, with a 12.03% increase in profit. The company's net worth Soared by an impressive increase of 32.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Lenimen Biotech had a promoter holding of 86.00% and a public holding of 14.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Lenimen Biotech has a workforce of 10 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lenimen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lenimen Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lenimen Biotech Private Limited last Annual general meeting of members was held on 30 Aug 2024 as per latest MCA records. was recorded as a recent event.
Lenimen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam. was recorded as a recent event.
The activity Saji Subrahmanyan was appointed as a Director was appointed as a Director on 08 Apr 2019 & has been associated with this company since 6 years 9 months . was completed.
Abdul Rahman Parappath Shibili was appointed as a Director was appointed as a Director on 18 Mar 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
The activity Pazhangat Kochumarakat Nazar was appointed as a Managing Director was appointed as a Managing Director on 18 Mar 2014 & has been associated with this company since 11 years 10 months . was completed.
Shahid Rahman Manthedath was appointed as a Director was appointed as a Director on 18 Mar 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
The CIN of Lenimen Biotech Private Limited is U24232KL2014PTC036433.
Lenimen Biotech Private Limited is headquartered at 2/76 B Ckk Building,Thottumugam, Aluva, Kerala, 683105.
Lenimen Biotech Private Limited was incorporated on 18 March 2014.
The current directors of Lenimen Biotech Private Limited are
The primary industry of Lenimen Biotech Private Limited is Trade.
Lenimen Biotech Private Limited is unlisted.
The authorized capital of Lenimen Biotech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lenimen Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX